For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed the day trading at $23.68 down -2.35% from the previous closing price of $24.25. In other words, the price has decreased by -$2.35 from its previous closing price. On the day, 0.64 million shares were traded. RCKT stock price reached its highest trading level at $24.5599 during the session, while it also had its lowest trading level at $23.485.
Ratios:
For a better understanding of RCKT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.80 and its Current Ratio is at 7.80. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Neutral rating and assigned the stock a target price of $39.
On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $65.
On February 01, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $45.Morgan Stanley initiated its Overweight rating on February 01, 2023, with a $45 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 15 ’24 when SOUTHWELL DAVID P sold 10,000 shares for $24.05 per share. The transaction valued at 240,520 led to the insider holds 114,784 shares of the business.
SOUTHWELL DAVID P sold 70,000 shares of RCKT for $1,705,265 on Apr 12 ’24. The Director now owns 95,160 shares after completing the transaction at $24.36 per share. On Apr 08 ’24, another insider, White Mark Andrew, who serves as the insider of the company, sold 12,532 shares for $24.64 each. As a result, the insider received 308,763 and left with 75,226 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 2143139456 and an Enterprise Value of 1795007616.
Stock Price History:
Over the past 52 weeks, RCKT has reached a high of $32.53, while it has fallen to a 52-week low of $14.89. The 50-Day Moving Average of the stock is -14.11%, while the 200-Day Moving Average is calculated to be 3.23%.
Shares Statistics:
Over the past 3-months, RCKT traded about 726.90K shares per day on average, while over the past 10 days, RCKT traded about 671160 shares per day. A total of 90.28M shares are outstanding, with a floating share count of 84.00M. Insiders hold about 7.19% of the company’s shares, while institutions hold 97.14% stake in the company. Shares short for RCKT as of 1711584000 were 10517069 with a Short Ratio of 14.47, compared to 1709164800 on 9961944. Therefore, it implies a Short% of Shares Outstanding of 10517069 and a Short% of Float of 15.14.
Earnings Estimates
The market rating for Rocket Pharmaceuticals Inc (RCKT) is a result of the insights provided by Rocket Companies, Inc. analysts actively involved in the assessment.The consensus estimate for the next quarter is $1.42, with high estimates of $33.72 and low estimates of $23.68.
